ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Assessing the Bleeding Phenotype in Non-Severe hemophilia by use of the ISTH Bleeding Assessment Tool (BAT)

F.R. Kloosterman1, A. Zwagemaker1, C.N. Bagot2, E.A.M. Beckers3, J.G. van der Bom4, P. Collins5, M.H. Cnossen6, M. Coppens7, S.C. Gouw1,4, B.A.P. Laros-van Gorkum8, S. Mangles9, F.J.M. van der Meer10, K. Meijer11, L. Nieuwenhuizen12, R. Schutgens13, K. Fijnvandraat1

1Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Amsterdam, the Netherlands, 2NHS Greater Glasgow and Clyde, Department of Thrombosis and Haemostasis, Glasgow, United Kingdom, 3Maastricht University Medical Center (MUMC+), Hematology, Maastricht, the Netherlands, 4Leiden University Medical Center, Clinical Epidemiology, Leiden, the Netherlands, 5Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, United Kingdom, 6Erasmus University Medical Center - Sophia Children's Hospital, Department of Paediatric Hematology, Rotterdam, the Netherlands, 7Amsterdam UMC, University of Amsterdam, Vascular Medicine, Amsterdam, the Netherlands, 8Radboud university medical center, Hematology, Nijmegen, the Netherlands, 9Basingstoke and Hampshire Hospital, Hampshire, the Netherlands, 10Leiden Univeristy Medical Center, Department of Thrombosis and Haemostasis, Leiden, the Netherlands, 11University Medical Center Groningen, Hematology, Groningen, the Netherlands, 12Maxima Medisch Centrum, Internal Medicine, Veldhoven, the Netherlands, 13Van Creveld Clinic, University Medical Center Utrecht, Utrecht, the Netherlands

Abstract Number: PB0897

Meeting: ISTH 2020 Congress

Theme: Hemophilia and Rare Bleeding Disorders » Hemophilia - Clinical

Background: Patients with non-severe hemophilia experience an increased bleeding tendency predominantly after provocative events such as trauma or surgery. Few studies have quantified the bleeding phenotype in this population. The International Society of Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) has been developed to objectively quantify bleeding symptoms and could provide insight into the extent of bleeding reported by non-severe hemophilia patients.

Aims: The aim of this study was to describe the phenotype of patients with non-severe hemophilia A and B using the patient reported ISTH-BAT.

Methods: The DYNAMO study is a cohort study that includes male congenital hemophilia A and B patients aged 12-55 years with a baseline clotting factor level of 2-35 IU/dL. ISTH-BAT scores were prospectively collected through an online questionnaire omitting gender-specific sections after written consent was obtained. The study was approved by the medical ethics committee (ClinicalTrials.gov Identifier: NCT03623295).

Results: In this preliminary analysis, 47/101 (47%) patients (37 HA and 10 HB) completed the questionnaire. The median age was 39 years (IQR 27-49) and the median FVIII/IX level was 12 IU/dL (IQR 6-17). We found a median ISTH-BAT score of 7 (IQR 3-13), with 74% reporting abnormal bleeding scores (≥4). Joint, muscle and mouth bleeds were reported most frequently (62, 45 and 45%) (Figure 1). Patients with moderate hemophilia (2-5 IU/dL) had higher ISTH-BAT scores compared to patients with mild hemophilia (5-35 IU/dL) (median ISTH-BAT score 10 vs 7). ISTH-BAT scores were similar between hemophilia A and B.

Conclusions: Patients with non-severe hemophilia A and B had a median ISTH-BAT of 7 with 74% of patients reporting abnormal bleeding scores. Patients with moderate hemophilia had higher ISTH-BAT-scores when compared to patients with mild hemophilia.


[Figure 1: Reported bleeding symptoms. Abbreviations; GI = gastro-intestinal, ICH = intracranial hemorrhage, Tooth Extr. = tooth extractions ]

To cite this abstract in AMA style:

Kloosterman FR, Zwagemaker A, Bagot CN, Beckers EAM, van der Bom JG, Collins P, Cnossen MH, Coppens M, Gouw SC, Laros-van Gorkum BAP, Mangles S, van der Meer FJM, Meijer K, Nieuwenhuizen L, Schutgens R, Fijnvandraat K. Assessing the Bleeding Phenotype in Non-Severe hemophilia by use of the ISTH Bleeding Assessment Tool (BAT) [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/assessing-the-bleeding-phenotype-in-non-severe-hemophilia-by-use-of-the-isth-bleeding-assessment-tool-bat/. Accessed September 21, 2023.

« Back to ISTH 2020 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/assessing-the-bleeding-phenotype-in-non-severe-hemophilia-by-use-of-the-isth-bleeding-assessment-tool-bat/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley